Pinnacle Associates LTD Bausch Health Companies Inc. Transaction History

Pinnacle Associates LTD

$6.3 Billion
Q3 2024

A detailed history of Pinnacle Associates LTD transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Pinnacle Associates LTD holds 29,500 shares of BHC stock, worth $226,560. This represents 0.0% of its overall portfolio holdings.

Number of Shares

29,500

Previous 30,819 4.28%

Holding current value

$226,560

Previous $214,000 12.15%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	SELL	$5.22 - $8.26 $6,885 - $10,894	-1,319 Reduced 4.28%	29,500 $240,000
Q2 2024 Jul 30, 2024	SELL	$6.1 - $10.41 $17,263 - $29,460	-2,830 Reduced 8.41%	30,819 $214,000
Q1 2024 Apr 26, 2024	BUY	$7.77 - $10.61 $32,237 - $44,020	4,149 Added 14.06%	33,649 $357,000
Q4 2023 Jan 19, 2024	SELL	$6.53 - $8.23 $653 - $823	-100 Reduced 0.34%	29,500 $236,000
Q3 2023 Oct 23, 2023	SELL	$7.69 - $9.71 $2,307 - $2,913	-300 Reduced 1.0%	29,600 $243,000
Q2 2023 Jul 26, 2023	SELL	$5.72 - $8.8 $15,444 - $23,760	-2,700 Reduced 8.28%	29,900 $239,000
Q1 2023 May 04, 2023	BUY	$6.28 - $9.85 $53,694 - $84,217	8,550 Added 35.55%	32,600 $264,000
Q4 2022 Jan 31, 2023	SELL	$6.09 - $7.93 $13,398 - $17,446	-2,200 Reduced 8.38%	24,050 $151,000
Q4 2022 Jan 25, 2023	SELL	$6.09 - $7.93 $24,969 - $32,513	-4,100 Reduced 13.51%	26,250 $0
Q3 2022 Oct 31, 2022	SELL	$4.58 - $9.21 $134,652 - $270,774	-29,400 Reduced 49.21%	30,350 $209,000
Q2 2022 Aug 02, 2022	BUY	$7.06 - $23.63 $251,865 - $843,000	35,675 Added 148.18%	59,750 $500,000
Q1 2022 May 05, 2022	SELL	$21.6 - $27.79 $8,640 - $11,116	-400 Reduced 1.63%	24,075 $550,000
Q4 2021 Feb 02, 2022	SELL	$23.0 - $29.01 $26,450 - $33,361	-1,150 Reduced 4.49%	24,475 $676,000
Q3 2021 Oct 19, 2021	SELL	$25.04 - $30.06 $22,536 - $27,054	-900 Reduced 3.39%	25,625 $714,000
Q2 2021 Aug 02, 2021	SELL	$27.43 - $32.7 $5,486 - $6,540	-200 Reduced 0.75%	26,525 $778,000
Q1 2021 May 12, 2021	SELL	$21.37 - $34.38 $158,138 - $254,412	-7,400 Reduced 21.68%	26,725 $848,000
Q4 2020 Jan 26, 2021	BUY	$15.31 - $21.12 $78,463 - $108,240	5,125 Added 17.67%	34,125 $710,000
Q3 2020 Oct 23, 2020	SELL	$14.88 - $20.13 $36,456 - $49,318	-2,450 Reduced 7.79%	29,000 $451,000
Q2 2020 Aug 14, 2020	BUY	$13.31 - $20.51 $5,324 - $8,204	400 Added 1.29%	31,450 $575,000
Q1 2020 May 13, 2020	BUY	$12.98 - $30.25 $220,660 - $514,250	17,000 Added 121.0%	31,050 $481,000
Q4 2019 Feb 03, 2020	SELL	$18.89 - $31.89 $944 - $1,594	-50 Reduced 0.35%	14,050 $420,000
Q3 2019 Nov 08, 2019	SELL	$20.88 - $25.66 $11,484 - $14,113	-550 Reduced 3.75%	14,100 $308,000
Q1 2019 May 10, 2019	BUY	$20.23 - $26.29 $91,035 - $118,305	4,500 Added 44.33%	14,650 $362,000
Q4 2018 Feb 05, 2019	BUY	$17.64 - $28.32 $38,808 - $62,304	2,200 Added 27.67%	10,150 $187,000
Q3 2018 Nov 13, 2018	BUY	$20.64 - $25.67 $164,088 - $204,076	7,950 New	7,950 $204,000

Others Institutions Holding BHC

# of Institutions

254

Shares Held

253M

Call Options Held

5.53M

Put Options Held

16.5M

View Full List

About Bausch Health Companies Inc.

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.78B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

More about BHC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Associates LTD, based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Associates LTD with notifications on news.

Account

Pinnacle Associates LTD Bausch Health Companies Inc. Transaction History